Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300

Yu Jeong Bang, Eduardo Yañez Ruiz, Eric Van Cutsem, +16

Annals of Oncology

Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

Thierry Conroy, Florence Castan, Anthony Lopez, +15

JAMA Oncology

Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study

Do‐Youn Oh, Aiwu Ruth He, Mohamed Bouattour, +39

˜The œLancet. Gastroenterology & hepatology

Overall SurvivalGastrointestinal OncologyMedicineRandomised Phase 3Biliary Cancer +5

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial

Miao‐Zhen Qiu, Do‐Youn Oh, Ken Kato, +29

BMJ

A Multicenter Experience With Infliximab for Ulcerative Colitis: Outcomes and Predictors of Response, Optimization, Colectomy, and Hospitalization

Abderrahim Oussalah, Ludovic Evesque, David Laharie, +8

The American Journal of Gastroenterology

Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial

Thierry Conroy, Florence Castan, Pierre-Luc Etienne, +17

Annals of Oncology

Surgical OncologyTotal Neoadjuvant TherapyGastrointestinal OncologyMedicineColorectal Cancer +6

Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: 7-year results of PRODIGE 23 phase III trial, a UNICANCER GI trial.

Thierry Conroy, Pierre-Luc Etienne, Emmanuel Rio, +17

Journal of Clinical Oncology

Surgical OncologyCancer ManagementAdjuvant ChemotherapySurgeryOncology +14

Planned organ preservation for early T2-3 rectal adenocarcinoma: A French, multicentre study

Jean‐Pierre Gérard, N. Barbet, Jocelyn Gal, +10

European Journal of Cancer

Transplantation SurgerySurgical OncologyColorectal SurgeryMedicineReconstructive Surgery +6

Effect of Detoxification on Liver Stiffness Assessed by Fibroscan® in Alcoholic Patients

Ève Gelsi, Raphaella Dainese, Régine Truchi, +8

Alcoholism Clinical and Experimental Research

Randomized phase III ANGEL study of rivoceranib (apatinib) + best supportive care (BSC) vs placebo + BSC in patients with advanced/metastatic gastric cancer who failed ≥2 prior chemotherapy regimens

Yoon‐Koo Kang, W. Kang, Maria Di Bartolomeo, +17

Annals of Oncology

OncologyGastrointestinal OncologyCancer ManagementClinical TrialsAdvanced/metastatic Gastric Cancer +6